Cancer

Adult patients with advanced cancer who are screened for pain with a standardized quantitative tool at each outpatient visit

Patients with metastatic colorectal cancer and RAS gene mutation spared treatment with anti-epidermal growth factor receptor monoclonal antibodies

2022 submission:

Percentage of patients who died from cancer, and admitted to hospice and spent less than 3 days there

Percentage of patients who died from cancer admitted to the ICU in the last 30 days of life

Percentage of patients who died from cancer receiving systemic cancer-directed therapy in the last 14 days of life

Percentage of patients, regardless of age, who undergo central venous catheter (CVC) insertion for whom CVC was inserted with all elements of maximal sterile barrier technique, hand hygiene, skin preparation and, if ultrasound is used, sterile ultrasound techniques followed

Proportion of patients who died from cancer not admitted to hospice

Percentage of patients, regardless of age, with a diagnosis of prostate cancer at low (or very low) risk of recurrence receiving interstitial prostate brachytherapy, OR external beam radiotherapy to the prostate, OR radical prostatectomy who did not have a bone scan performed at any time since diagnosis of prostate cancer

Percentage of patients, regardless of age, with a diagnosis of prostate cancer at low (or very low) risk of recurrence receiving interstitial prostate brachytherapy, OR external beam radiotherapy to the prostate, OR radical prostatectomy who did not have a bone scan performed at any time since diagnosis of prostate cancer